Abstract
Treatment with Imetelstat Improves Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in Patients with Relapsed or Refractory Higher-Risk Myelofibrosis
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have